Agenus to Participate in Upcoming September Investor Conferences
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that Robin Taylor, Ph.D., Chief Commercial Officer, and Zack Armen, Head of Corporate Development and Investor Relations, will participate in fireside chats and one-on-one investor meetings at two upcoming investor conferences in September.
Cantor Global Healthcare Conference 2026
September 9 -11, 2026; New York, NY
Fireside Chat: Tuesday, September 8, 2026 | 11:30 a.m-12:00 p.m. ET
